Panna Sharma | executive |
David Margrave | executive |
Good afternoon, and welcome to our fourth quarter and year-end 2023 earnings call.
As a reminder, this call is being recorded, and all attendees are in a listen-only mode.
We will open the call for questions and answers after our management's presentation. A webcast replay of today's conference call will be available on our website at lanternpharma.com shortly after the call. We issued a press release after market close today, summarize our financial results and progress across the company for the fourth quarter and year ended December 31, 2023.